Hence then, the article about biocity will present the late breaking clinical trial data of its eta selective antagonist sc0062 at the american society of nephrology asn 2024 with simultaneous publication of the trial data in the journal of the american society of nep was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( BioCity will present the late-breaking clinical trial data of its ETA selective antagonist SC0062 at the American Society of Nephrology (ASN) 2024 with simultaneous publication of the trial data in the Journal of the American Society of Nep )
Also on site :
- You're Probably Wasting $200 a Month on These Sneaky Bills
- Lucid Motors’ new CEO cuts 18% of staff to ‘simplify the company’
- Olivia Rodrigo Charts All 13 Songs From ‘You Seem Pretty Sad for a Girl So in Love’ in Hot 100’s Top 30